Don’t be so arrogantly ignorant! A few months ago there was the release of a new contraceptive pill in Uk. £8 /month. No insurance! I would bet it has it will gain a bigger market share than Nextellis with little marketing costs in no time. You say Mithra sales are irrelevant to Mayne. How ridiculous! Of course it’s relevant when Mayne are 80% of their revenue. Did you read their annual report? You say Metrics was a liability. It was sold for nearly 3x total value of Mayne now. It was a profitable and the most valuable portion of Mayne. No insurance company is going to fork out over $2000.00/ year for each and every woman taking Nextellis. You seem to be illogical in your analysis.
MYX Price at posting:
$3.09 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)